Home/Legend Biotech/Dr. Michael Goller
DM

Dr. Michael Goller

Director

Legend Biotech

Roles

DirectoratLegend Biotech
Board MemberatDBV Technologies

Legend Biotech Pipeline

DrugIndicationPhase
CARVYKTI (ciltacabtagene autoleucel)Relapsed/Refractory Multiple MyelomaApproved
LB1901Relapsed/Refractory T-cell Lymphoma (Adult T-cell Leukemia/Lymphoma)Phase 1
LB2102Extensive-Stage Small Cell Lung Cancer (SCLC)Phase 1
LB1908Gastric, Pancreatic, and Colorectal CancersPhase 1
LB-ALLO1Relapsed/Refractory Multiple MyelomaPre-clinical